ZYBAN (BUPROPION HYDROCHLORIDE) — FDA Approval NDA020711 (GLAXOSMITHKLINE)
ZYBAN (BUPROPION HYDROCHLORIDE) — FDA Approval NDA020711 (GLAXOSMITHKLINE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ZYBAN; Active ingredients: BUPROPION HYDROCHLORIDE; Application number: NDA020711.
| Brand name | ZYBAN |
|---|---|
| Active ingredients | BUPROPION HYDROCHLORIDE |
| Application number | NDA020711 |
| Sponsor | GLAXOSMITHKLINE |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19970514 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →